BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 35295028)

  • 1. Investigation of two general venous thromboembolism risk-stratification models in predicting venous thromboembolic events in TB patients.
    Sharif-Kashani B; Azimi M; Tabarsi P; Sadr M; Shirzadi S
    Int J Mycobacteriol; 2022; 11(1):83-87. PubMed ID: 35295028
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Venous thromboembolism (VTE) risk stratification in general medical patients at an academic medical center.
    Fritz MK; Kincaid SE; Sargent CG; Green AH; Davis GA
    J Thromb Thrombolysis; 2021 Jan; 51(1):67-73. PubMed ID: 32447745
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ability of Caprini and Padua risk-assessment models to predict venous thromboembolism in a nationwide Veterans Affairs study.
    Hayssen H; Sahoo S; Nguyen P; Mayorga-Carlin M; Siddiqui T; Englum B; Slejko JF; Mullins CD; Yesha Y; Sorkin JD; Lal BK
    J Vasc Surg Venous Lymphat Disord; 2024 Mar; 12(2):101693. PubMed ID: 37838307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk Assessment Models for Venous Thromboembolism in Medical Inpatients.
    Häfliger E; Kopp B; Darbellay Farhoumand P; Choffat D; Rossel JB; Reny JL; Aujesky D; Méan M; Baumgartner C
    JAMA Netw Open; 2024 May; 7(5):e249980. PubMed ID: 38728035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical impact of application of risk assessment models (Padua Prediction Score and Improve Bleeding Score) on venous thromboembolism, major hemorrhage and health expenditure associated with pharmacologic VTE prophylaxis: a "real life" prospective and retrospective observational study on patients hospitalized in a Single Internal Medicine Unit (the STIME study).
    Depietri L; Marietta M; Scarlini S; Marcacci M; Corradini E; Pietrangelo A; Ventura P
    Intern Emerg Med; 2018 Jun; 13(4):527-534. PubMed ID: 29502330
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Caprini versus Padua venous thromboembolism risk assessment scores: A comparative study in hospitalized patients at a tertiary center.
    Trabulsi N; Khafagy AM; Alhazmi LS; Alghamdi AM; Alzahrani AA; Banaamah MM; Farsi A; Shabkah A; Samkari A; Al-Hajeili M; Abduljabbar A; Wazzan M
    Saudi Med J; 2024 Apr; 45(4):362-368. PubMed ID: 38657986
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk assessment models for venous thromboembolism in acutely ill medical patients. A systematic review.
    Stuck AK; Spirk D; Schaudt J; Kucher N
    Thromb Haemost; 2017 Apr; 117(4):801-808. PubMed ID: 28150851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. External Validation of a Venous Thromboembolic Risk Score for Cancer Outpatients with Solid Tumors: The COMPASS-CAT Venous Thromboembolism Risk Assessment Model.
    Spyropoulos AC; Eldredge JB; Anand LN; Zhang M; Qiu M; Nourabadi S; Rosenberg DJ
    Oncologist; 2020 Jul; 25(7):e1083-e1090. PubMed ID: 32017293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk assessment models for venous thromboembolism in hospitalised adult patients: a systematic review.
    Pandor A; Tonkins M; Goodacre S; Sworn K; Clowes M; Griffin XL; Holland M; Hunt BJ; de Wit K; Horner D
    BMJ Open; 2021 Jul; 11(7):e045672. PubMed ID: 34326045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The timing of venous thromboembolic events after spine surgery: a single-center experience with 6869 consecutive patients.
    Cloney MB; Hopkins B; Dhillon ES; Dahdaleh NS
    J Neurosurg Spine; 2018 Jan; 28(1):88-95. PubMed ID: 29125431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Performance of Risk Assessment Models for Peripartum Thromboprophylaxis.
    Tran JP; Stribling SS; Ibezim UC; Omere C; McEnery KA; Pacheco LD; Hankins GD; Saade GR; Saad AF
    Reprod Sci; 2019 Sep; 26(9):1243-1248. PubMed ID: 30486735
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Prospective Observational Cohort of Clinical Outcomes in Medical Inpatients prescribed Pharmacological Thromboprophylaxis Using Different Clinical Risk Assessment Models(COMPT RAMs).
    Chamoun N; Matta S; Aderian SS; Salibi R; Salameh P; Tayeh G; Haddad E; Ghanem H
    Sci Rep; 2019 Dec; 9(1):18366. PubMed ID: 31797897
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validation of Risk Assessment Models Predicting Venous Thromboembolism in Inpatients with Acute Exacerbation Of Chronic Obstructive Pulmonary Disease: A Multicenter Cohort Study in China.
    Zhou C; Yi Q; Ge H; Wei H; Liu H; Zhang J; Luo Y; Pan P; Zhang J; Peng L; Aili A; Liu Y; Wang M; Tang Y; Wang L; Zhong X; Wang Y; Zhou H;
    Thromb Haemost; 2022 Jul; 122(7):1177-1185. PubMed ID: 34758489
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison between Caprini and Padua risk assessment models for hospitalized medical patients at risk for venous thromboembolism: a retrospective study.
    Liu X; Liu C; Chen X; Wu W; Lu G
    Interact Cardiovasc Thorac Surg; 2016 Oct; 23(4):538-43. PubMed ID: 27297558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of inpatient versus post-discharge venous thromboembolic events after spinal surgery: A single institution series of 6869 consecutive patients.
    Cloney MB; Driscoll CB; Yamaguchi JT; Hopkins B; Dahdaleh NS
    Clin Neurol Neurosurg; 2020 Sep; 196():105982. PubMed ID: 32570019
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk assessment of venous thromboembolism and bleeding in COVID-19 patients.
    Wang L; Zhao L; Li F; Liu J; Zhang L; Li Q; Gu J; Liang S; Zhao Q; Liu J; Xu JF
    Clin Respir J; 2022 Mar; 16(3):182-189. PubMed ID: 35060325
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative Performance of Clinical Risk Assessment Models for Hospital-Acquired Venous Thromboembolism in Medical Patients.
    Blondon M; Spirk D; Kucher N; Aujesky D; Hayoz D; Beer JH; Husmann M; Frauchiger B; Korte W; Wuillemin WA; Bounameaux H; Righini M; Nendaz M
    Thromb Haemost; 2018 Jan; 118(1):82-89. PubMed ID: 29304528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Missed opportunities for venous thromboembolism prophylaxis during pregnancy and the postpartum period: evidence from mainland China in 2019.
    Zhao Z; Zhou Q; Li X
    BMC Pregnancy Childbirth; 2021 May; 21(1):400. PubMed ID: 34030656
    [TBL] [Abstract][Full Text] [Related]  

  • 19. COMPASS-CAT versus Khorana risk assessment model for predicting venous thromboembolic events in patients with non-small cell lung cancer on active treatment with chemotherapy and/or immunotherapy, the CK-RAM study.
    Abdel-Razeq H; Sharaf B; Al-Jaghbeer MJ; Abu-Fares H; Bater R; Shaer MA; Abu-Jaish H; Laban DA; Salamah O; Tamimi F; Ashouri K; Salameh T; Zughul R; Alhalaseh Y
    J Thromb Thrombolysis; 2023 Oct; 56(3):447-453. PubMed ID: 37430158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Application of Padua prediction score and serum albumin level in evaluating venous thromboembolism in rheumatic inpatients].
    Peng Q; Liu JJ; Liu Y; Shang H; Tang G; Han YX; Long L
    Beijing Da Xue Xue Bao Yi Xue Ban; 2023 Aug; 55(4):625-630. PubMed ID: 37534642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.